Press Release

Filter
Filter by:
Show All
01November
2022

Hilleman Laboratories to Develop A Thermostable Second-Generation Zaire Ebolavirus Vaccine In Collaboration with MSD

Read More
27October
2022

SK bioscience and Hilleman Laboratories to Co-develop New Vaccine Platforms

Read More
04October
2022

International Vaccine Institute Signs Memorandum of Understanding with Hilleman Laboratories to Advance Vaccine R&D and Manufacturing for Safe, Effective, and Affordable Vaccines in Low-and Middle-Income Countries

Read More
22February
2022

Hilleman Laboratories breaks ground on pilot cGMP facility for vaccine development

Read More
06December
2021

Hilleman Laboratories establishes pilot manufacturing facility for vaccine development in Singapore with support from Singapore Economic Development Board

Read More